Chromosomal abnormalities and tumor development: FRom genes to therapeutic mechanisms

BioEssays

Volumn 20, Issue 11, 1998, Pages 922-930

  Cobaleda, C ^a   Perez Losada J ^a   Sanchez Garcia I ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

APOPTOSIS; BIOLOGICAL MODEL; CHIMERA; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; GENE EXPRESSION REGULATION; GENE FUSION; GENE TRANSLOCATION; GENETICS; HUMAN; NEOPLASM; REVIEW;

APOPTOSIS; ARTIFICIAL GENE FUSION; CHIMERA; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; GENE EXPRESSION REGULATION; HUMANS; MODELS, GENETIC; NEOPLASMS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0345451024     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199811)20:11<922::AID-BIES7>3.0.CO;2-O     Document Type: Review

References (73)

1. Bishop JM (1995) Cancer: the rise of the genetic paradigm. Genes Dev 9: 1309-1315.
2. Mitelman F, Mertens F, Johansson BA (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417-474.
3. Tsujimoto Y, Gorham I, Cossman J, Jaffe E, Croce CM (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393.
4. Sánchez-García I, Rabbitts TH (1993) LIM-domain proteins in leukemia and development. Semin Cancer Biol 4: 349-358.
5. Sánchez-García I, Kaneko Y, González-Sarmiento R, Campbell K, White L, Boehm T, Rabbitts TH (1991) A study of chromosome 11p 13 translocations involving TCR-β and TCR-d in human T cell leukemia. Oncogene 6: 577-582
6. Rabbitts TH (1994) Chromosomal translocations in human cancer Nature 372: 143-149.
7. Sánchez-García I (1997) Consequences of chromosomal abnormalities in tumor development. Annu Rev Genet 31: 429-453.
8. De Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300: 765-767.
9. Sánchez-García I, Rabbitts TH (1994) Transcriptional activation by proteins expressed in acute malignancies as a result of chromosomal abnormalities: TAL1 and FUS-CHOP proteins. Proc Natl Acad Sci USA 91: 7869-7873.
10. Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ (1991) Deregulation of a homeobox, HOX11, by the t(10;14) in T cell leukemia. Science 253: 79-82.
11. Keneddy MA, González-Sarmiento R, Kees UR, Lampert F, Dera N, Boehm T, Rabbitts TH (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci USA 88: 8900-8904.
12. Lu M, Gong Z, Shen W, Ho AD (1991) The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein. EMBO J 10: 2905-2910.
13. Kamps MP, Murre C, Sun X-H, Baltimore D (1990) A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60: 547-555.
14. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60: 535-545.
15. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Amanuel BS (1993) Rearrangement of PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma. Nat Genet 3: 113-117.
16. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54: 2869-2872.
17. Galili N, Davies RJ, Fredericks WJ, Mulkhopadhyoy S, Rauscher FJ, Emanuel BS, Ravera G, Barr FG (1993) Fusion of a forkhead domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nat Genet 5: 230-235.
18. Klampfer L, Zhang J, Zelenetz AO, Uchida H, Nimer SD (1996) The AML1/ETO fusion protein activates transcription of BCL-2. Proc Natl Acad Sci USA 93: 14059-14064.
19. Sánchez-García I, Rabbitts TH (1994) LIM domain: a new structural class of zinc-finger like proteins. Trends Genet 10: 315-320.
20. Hunger SP, Ohyashiki K, Toyama K, Clearly ML (1992) Hlf, a novel hepatic bZIP protein, shows altered DMA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 6: 1608-1620.
21. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT (1992) Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257: 531-534.
22. Knight JC, Renwick PJ, Dal CP, Van den Berghe H, Fletcher CDM (1995) Translocation t(12;16)(q13;q22) in myxoid liposarcoma and round cell liposarcoma: a molecular and cytogenetic analysis. Cancer Res 55: 24-27.
23. Crozat A, Aman P, Mandahl N, Ron D (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363: 640-644.
24. Rabbitts TH, Forster A, Larson R, Nathan P (1993) Fusion at the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4: 175-180.
25. Ron D, Habener JF (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP functions as a dominant negative inhibitor of gene transcription. Genes Dev 6: 439-453.
26. Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994) A RNA-binding protein gene, TLS/ FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54: 2865-2868.
27. Panagopoulos I, Aman P, Fioretos T, Höglund M, Johansson B, et al. (1994) Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11: 256-262.
28. Panagopoulos I, Mandahl N, Mitelman F, Aman P (1995) Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21). Oncogene 11: 1133-1137.
29. Batchvarova N, Wang XZ, Ron D (1995) Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J 14:4654-4661.
30. Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Maseki N, et al. (1993) An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc Natl Acad Sci USA 90: 10280-10284.
31. Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ESP (1994) TLS/ FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9: 3717-3729.
32. Zinszner H, Albalat R, Ron D (1994) A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogene transformation by CHOP. Genes Dev 8: 2513-2526.
33. Jeon I-S, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN (1995) A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10: 1229-1234.
34. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT, (1994) A second Ewing's sarcoma translocation t(21;22) fuses the EWS gene to another ETS-family transcription factor ERG. Nat Genet 6: 146-151.
35. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, et al. (1993) EWS and ATF1 gene fusion induced by t(12,22) translocation in malignant melanoma of soft parts. Nat Genet 4: 341-345.
36. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, et al. (1993) Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J 12: 4481-4487.
37. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, et al. (1993) The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13: 7393-7398.
38. Gerald WL, Rosai J, Ladanyi M (1995) Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci USA 92: 1028-1032.
39. Ladanyi M, Gerald W (1994) Fusion of the EWS and WT1 genes in desmoplastic small round cell tumors. Cancer Res 54: 2837-2840.
40. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ (1993) WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splice variant. Science 262: 2057-2059.
41. Cooper SC (1996) Translocations in solid tumors. Curr Opin Genet Dev 6: 71-75.
42. Knight JC, Reeves BR, Smith S, Clark J, Fisher C, et al. (1992) Cytogenetic and molecular analysis of synovial sarcoma. Int J Oncol 1: 747-452.
43. Limon J, Mrozek K, Mandahl N, Nedoszytko B, Verhest A, et al. (1991) Cytogenetics of synovial sarcomas: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3: 338-345.
44. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, et al. (1994) Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2; q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502-508.
45. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, et al. (1995) Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to Krüppel-associated box in human synovial sarcoma. EMBO J 14: 2333-2340.
46. Shipley JM, Clark J, Crew AJ, Birdsall S, Rocques PJ, et al. (1994) The t(X;18)(p11.2; q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 9: 1447-1453.
47. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, et al. (1995) Disruption of the architectural factor HMGI-C, DNA binding AT hook motif fused in lipomas to distinct transcriptional regulatory domains. Cell 82: 57-64.
48. Schoemakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven JM (1995) Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nat Genet 10: 437-443.
49. Kamps MP, Wright DD, Lu Q (1996) DNA-binding by oncoprotein E2A-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene 12: 19-30.
50. Monica K, Lebrun P, Dedera DA, Brown R, Cleary ML (1994) Transforming properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 14: 8304-83014.
51. Inukai T, Inaba T, Yoshihara T, Look AT (1997) Cell transformation mediated by homodimeric E2A-HLF transcription factors. Mol Cell Biol 17: 1417-1424.
52. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41: 899-906.
53. Cleary ML, Sklar J (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82: 7439-7443.
54. McDonnell TJ, Deane N, Platt FM, Núñez G, Jaeger V, McKearn JP, Korsmeyer SJ (1989) Bcl 2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-88.
55. McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254-256.
56. Strasser A, Harris A, Bath ML, Cory S (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333.
57. Christofori G, Naik P, Hanahau D (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418.
58. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, et al. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
59. Cortez D, Stoica G, Pierce JH, Pendergast AM (1996) The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 13: 2589-2594.
60. Sánchez-García I, Grütz G (1995) The tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL-2. Proc Natl Acad Sci USA 92: 5287-5291.
61. Sánchez-García I, Martín-Zanca D (1997) Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras. J Mol Biol 267:225-228.
62. Grignani F, et al. (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74: 423-431.
63. Frampton J, Ramqvist T, Graf T (1996) v-Myb of E26 leukeima virus up-regulates bcl-2 and supresses apoptosis in myeloid cells. Genes Dev 10: 2720-2731.
64. Leroy-Viard K, Vinit M-A, Lecointe N, Jouault H, Hibner U, Roméo PH, Mathieu-Mahul D (1995). Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J 14: 2341-2349.
65. Yi H-K, Fujimura Y, Ouchida M, Prasad DDK, Rao VN, Reddy ESP (1997) Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 14: 1259-1268.
66. Osborne BA (1996) Cell death in vertebrates: lessons from the worm. Trends Genet 12: 489-491.
67. Zion M, Ben-Yehuda D, Avraham A, Cohen O, et al. (1994) Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc Natl Acad Sci USA 91: 10722-10726.
68. Choo Y, Sánchez-García I, Klug A (1994) In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372: 642-645.
69. Choo Y, Castellanos-Martín A, García Hernández B, Sánchez-García I, Klug A (1997) Promoter-specific activation of gene expression directed by phage-selected zinc fingers. J Mol Biol 273: 525-532.
70. p190 cells. Mol Med 2:125-133.
71. García Hernández B, Castellanos A, López A, Orfao A, Sánchez-García I (1997) Murine haematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells. Proc Natl Acad Sci USA 94:13239-13244.
72. Bedi A, Barber JP, Bedi GC, EI-Deiry WS, Sidransky D, et al. (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood 86: 1148-1158.
73. Kawabe T, Muslin AJ, Korsmeyer SJ (1997) HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature 385: 454-458.